Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02852265 · ClinicalTrials.gov registry record · Phase 4
Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study
A Phase 4 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02852265 is a Phase 4 study that has completed, run by University of California, Davis. The registered enrollment target is 20 participants.
The verdict
NCT02852265, a Phase 4 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.
Interventions
- DRUG Etonogestrel contraceptive implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09-15 |
| Est. Completion | 2017-07-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02852265
The ClinicalTrials.gov registry entry for NCT02852265 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Etonogestrel contraceptive implant is the first listed.
NCT02852265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02852265 about?
NCT02852265 is a clinical study titled "Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study". Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.
What is the current status of trial NCT02852265?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2016-09-15. Estimated completion is 2017-07-26.
What interventions are being tested in trial NCT02852265?
The interventions under investigation include: Etonogestrel contraceptive implant (DRUG).
Who is sponsoring clinical trial NCT02852265?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.